Blau Farmacêutica S.A.

São Paulo Stock Exchange BLAU3.SA

Blau Farmacêutica S.A. Dividend Yield on January 14, 2025: 3.75%

Blau Farmacêutica S.A. Dividend Yield is 3.75% on January 14, 2025, a 52.00% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.
  • Blau Farmacêutica S.A. 52-week high Dividend Yield is 4.40% on June 20, 2024, which is 17.21% above the current Dividend Yield.
  • Blau Farmacêutica S.A. 52-week low Dividend Yield is 2.47% on January 15, 2024, which is -34.21% below the current Dividend Yield.
  • Blau Farmacêutica S.A. average Dividend Yield for the last 52 weeks is 3.38%.
Key data
Date Dividend Yield Free Cash Flow Yield Earnings Yield Enterprise Value (EV)
Market news
Loading...
São Paulo Stock Exchange: BLAU3.SA

Blau Farmacêutica S.A.

CEO Mr. Marcelo Rodolfo Hahn
IPO Date April 19, 2021
Location Brazil
Headquarters Rodovia Raposo Tavares, 2833, km 30,5
Employees 1,900
Sector Health Care
Industries
Description

Blau Farmacêutica S.A., a pharmaceutical company provides private label drugs in Brazil, Argentina, Colombia, the United States, Ecuador, Peru, and Uruguay. The company's medications cover various therapeutic classes, such as immunology, hematology, oncology, nephrology, specialties, and antibiotics. It also offers biological drugs; oral and injectable drugs for treating cancer; specialized treatments for infectious diseases; and prescription and non-prescription drugs, including dermo-medicines, condoms, and others for retail and non-retail markets. In addition, the company provides blood-derived, biological, biotechnological, and antiretroviral drugs. It serves hospitals, private clinics, chemotherapy and hemodialysis centers, and public health institutions. The company was incorporated in 1987 and is headquartered in Cotia, Brazil.

StockViz Staff

January 15, 2025

Any question? Send us an email